ReP USP - Resultado da busca

Artigo de periodico
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice (2020)
Wang, Chih-Hao; Lundh, Morten; Fu, Accalia; Kriszt, Rókus; Huang, Tian Lian; Lynes, Matthew D.; Leiria, Luiz Osório Silveira ; Shamsi, Farnaz; Darcy, Justin; Greenwood, Bennett P.; Narain, Niven R.; Tolstikov, Vladimir; Smith, Kyle L.; Emanuelli, Brice; Chang, Young-Tae; Hagen, Susan; Danial, Nika N.; Kiebish, Michael A.; Tseng, Yu-Hua
Fonte: Science Translational Medicine. Unidade: FMRP
Assuntos: TECIDO ADIPOSO, DIETA, OBESIDADE, TERMOGÊNESE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Chih-Hao et al. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, v. 12, n. 558, 2020Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aaz8664. Acesso em: 02 nov. 2024.
APA
Wang, C. -H., Lundh, M., Fu, A., Kriszt, R., Huang, T. L., Lynes, M. D., et al. (2020). CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice. Science Translational Medicine, 12( 558). doi:10.1126/scitranslmed.aaz8664
NLM
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Vancouver
Wang C-H, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LOS, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang Y-T, Hagen S, Danial NN, Kiebish MA, Tseng Y-H. CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice [Internet]. Science Translational Medicine. 2020 ; 12( 558):[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aaz8664
Artigo de periodico
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression (2016)
Yong, Kol Jia; Bassères, Daniela Sanchez ; Welner, Robert S; Zhang, Wen Cai; Yang, Henry; Yan, Benedict; Jorda, Meritxell Alberich; Zhang, Junyan; Pontes, Lorena Lobo de Figueiredo; Battelli, Chiara; Hetherington, Christopher J; Ye, Min; Zhang, Hong; Maroni, Giorgia; O'Brien, Karen; Magli, Maria Cristina; Borczuk, Alain C; Varticovski, Lyuba; Kocher, Olivier; Zhang, Pu; Moon, Young-Choon; Sydorenko, Nadiya; Cao, Liangxian; Davis, Thomas W; Thakkar, Bhavin M; Soo, Ross A; Iwama, Atsushi; Lim, Bing; Halmos, Balazs; Neuberg, Donna; Tenen, Daniel G; Levantini, Elena
Fonte: Science Translational Medicine. Unidade: IQ
Assuntos: NEOPLASIAS, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YONG, Kol Jia et al. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, v. 8, n. 350, p. 1-10 art. 350ra104, 2016Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aad6066. Acesso em: 02 nov. 2024.
APA
Yong, K. J., Bassères, D. S., Welner, R. S., Zhang, W. C., Yang, H., Yan, B., et al. (2016). Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression. Science Translational Medicine, 8( 350), 1-10 art. 350ra104. doi:10.1126/scitranslmed.aad6066
NLM
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Vancouver
Yong KJ, Bassères DS, Welner RS, Zhang WC, Yang H, Yan B, Jorda MA, Zhang J, Pontes LL de F, Battelli C, Hetherington CJ, Ye M, Zhang H, Maroni G, O'Brien K, Magli MC, Borczuk AC, Varticovski L, Kocher O, Zhang P, Moon Y-C, Sydorenko N, Cao L, Davis TW, Thakkar BM, Soo RA, Iwama A, Lim B, Halmos B, Neuberg D, Tenen DG, Levantini E. Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBP alpha expression [Internet]. Science Translational Medicine. 2016 ; 8( 350): 1-10 art. 350ra104.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aad6066
Artigo de periodico
The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease (2015)
Sidman, Richard L; Li, Jianxue; Lawrence, Matthew; Hu, Wenzheng; Musso, Gary F; Giordano, Ricardo José ; Cardó-Vila, Marina; Pasqualini, Renata; Arap, Wadih
Fonte: Science Translational Medicine. Unidade: IQ
Assuntos: DOENÇAS RETINIANAS, RECEPTORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIDMAN, Richard L et al. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, v. 7, p. 1-15 art. 309, 2015Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.aac4882. Acesso em: 02 nov. 2024.
APA
Sidman, R. L., Li, J., Lawrence, M., Hu, W., Musso, G. F., Giordano, R. J., et al. (2015). The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease. Science Translational Medicine, 7, 1-15 art. 309. doi:10.1126/scitranslmed.aac4882
NLM
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Vancouver
Sidman RL, Li J, Lawrence M, Hu W, Musso GF, Giordano RJ, Cardó-Vila M, Pasqualini R, Arap W. The peptidomimetic vasotide targets two retinal VEGF receptors and reduces pathological angiogenesis in murine and nonhuman primate models of retinal disease [Internet]. Science Translational Medicine. 2015 ; 7 1-15 art. 309.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.aac4882
Artigo de periodico
A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice (2014)
Biressi, Stefano; Miyabara, Elen Haruka ; Gopinath, Suchitra D.; Carlig, Poppy M. M.; Rando, Thomas A.
Fonte: Science Translational Medicine. Unidade: ICB
Assunto: ANATOMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BIRESSI, Stefano et al. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Science Translational Medicine, v. 6, n. 267, p. 1-12, 2014Tradução . . Disponível em: https://doi.org/10.1126/scitranslmed.3008411. Acesso em: 02 nov. 2024.
APA
Biressi, S., Miyabara, E. H., Gopinath, S. D., Carlig, P. M. M., & Rando, T. A. (2014). A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Science Translational Medicine, 6( 267), 1-12. doi:10.1126/scitranslmed.3008411
NLM
Biressi S, Miyabara EH, Gopinath SD, Carlig PMM, Rando TA. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice [Internet]. Science Translational Medicine. 2014 ; 6( 267): 1-12.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3008411
Vancouver
Biressi S, Miyabara EH, Gopinath SD, Carlig PMM, Rando TA. A Wnt-TGFβ2 axis induces a fibrogenic program in muscle stem cells from dystrophic mice [Internet]. Science Translational Medicine. 2014 ; 6( 267): 1-12.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1126/scitranslmed.3008411

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos